SEARCH:   Advanced

Blood, Vol. 113, Issue 1, 224-232, January 1, 2009 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Central role of Sp1-regulated CD39 in hypoxia/ischemia protection Blood Eltzschig et al. 113: 224 Supplemental materials for: Eltzschig et al Files in this Data Supplement: Figure S1. Dimethyloxaloylglycine (DMOG) treatment results in cardiac CD39 induction (JPG, 54.4 KB) - (A) To study the effects of DMOG on cardiac CD39 expression, C57BL/6 mice were treated with1mg i.p. DMOG. Hearts were excised after indicated time periods, and CD39 transcript levels were determined by real-time RT-PCR. Beta-actin was used as internal standard to control for starting template. (B) Immunohistochemistry for CD39 following DMOG treatment. Figure S2. Cardiac ATP, AMP, and adenosine levels following ischemia (JPG, 38.4 KB) - Cardiac tissues derived from cd39−∕− or corresponding littermate controls (cd39+/+) following sham operation (C, control) or myocardial ischemia (60 min of coronary artery ligation) were flash frozen and nucleotide levels (ATP, AMP or adenosine) were determined via HPLC. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020